MarketPeel
EVP R&D, Chief Medical Officer
Wed, Feb 16, 2022
Feb 16
exercised or converted securities in ALKS
3,375 shares @ $0.00
Increased holdings by +35.50%
Net across this filing: -8.30% (-1,069 shares)
ALKSAlkermes plc.
Health CarePharmaceuticals
1D+0.70%
1W-0.55%
1M-6.96%
3M+29.19%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback